Literature DB >> 25297838

Biphasic modulation by mGlu5 receptors of TRPV1-mediated intracellular calcium elevation in sensory neurons contributes to heat sensitivity.

T Masuoka1, T Nakamura, M Kudo, J Yoshida, Y Takaoka, N Kato, T Ishibashi, N Imaizumi, M Nishio.   

Abstract

BACKGROUND AND
PURPOSE: Elevation of glutamate, an excitatory amino acid, during inflammation and injury plays a crucial role in the reception and transmission of sensory information via ionotropic and metabotropic receptors. This study aimed to investigate the mechanisms underlying the biphasic effects of metabotropic glutamate mGlu5 receptor activation on responses to noxious heat. EXPERIMENTAL APPROACH: We assessed the effects of intraplantar quisqualate, a non-selective glutamate receptor agonist, on heat and mechanical pain behaviours in mice. In addition, the effects of quisqualate on the intracellular calcium response and on membrane currents mediated by TRPV1 channels, were examined in cultured dorsal root ganglion neurons from mice. KEY
RESULTS: Activation of mGlu5 receptors in hind paw transiently increased, then decreased, the response to noxious heat. In sensory neurons, activation of mGlu5 receptors potentiated TRPV1-mediated intracellular calcium elevation, while terminating activation of mGlu5 receptors depressed it. TRPV1-induced currents were potentiated by activation of mGlu5 receptors under voltage clamp conditions and these disappeared after washout. However, voltage-gated calcium currents were inhibited by the mGlu5 receptor agonist, even after washout. CONCLUSIONS AND IMPLICATIONS: These results suggest that, in sensory neurons, mGlu5 receptors biphasically modulate TRPV1-mediated intracellular calcium response via transient potentiation of TRPV1 channel-induced currents and persistent inhibition of voltage-gated calcium currents, contributing to heat hyper- and hypoalgesia.
© 2014 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25297838      PMCID: PMC4314192          DOI: 10.1111/bph.12962

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  46 in total

1.  Internalization of ionotropic glutamate receptors in response to mGluR activation.

Authors:  E M Snyder; B D Philpot; K M Huber; X Dong; J R Fallon; M F Bear
Journal:  Nat Neurosci       Date:  2001-11       Impact factor: 24.884

2.  Peripheral group I metabotropic glutamate receptors modulate nociception in mice.

Authors:  G Bhave; F Karim; S M Carlton; R W Gereau
Journal:  Nat Neurosci       Date:  2001-04       Impact factor: 24.884

Review 3.  Pharmacology of ionotropic glutamate receptors: A structural perspective.

Authors:  Philipp Stawski; Harald Janovjak; Dirk Trauner
Journal:  Bioorg Med Chem       Date:  2010-09-19       Impact factor: 3.641

4.  Amino acid release into the knee joint: key role in nociception and inflammation.

Authors:  N B Lawand; T McNearney; K N Westlund
Journal:  Pain       Date:  2000-05       Impact factor: 6.961

5.  Phospholipid metabolism is required for M1 muscarinic inhibition of N-type calcium current in sympathetic neurons.

Authors:  Liwang Liu; Mandy L Roberts; Ann R Rittenhouse
Journal:  Eur Biophys J       Date:  2004-03-05       Impact factor: 1.733

6.  Quantitative assessment of tactile allodynia in the rat paw.

Authors:  S R Chaplan; F W Bach; J W Pogrel; J M Chung; T L Yaksh
Journal:  J Neurosci Methods       Date:  1994-07       Impact factor: 2.390

7.  Molecular reconstruction of mGluR5a-mediated endocannabinoid signaling cascade in single rat sympathetic neurons.

Authors:  Yu-Jin Won; Henry L Puhl; Stephen R Ikeda
Journal:  J Neurosci       Date:  2009-10-28       Impact factor: 6.167

8.  Regulation of eukaryotic initiation factor 4E by converging signaling pathways during metabotropic glutamate receptor-dependent long-term depression.

Authors:  Jessica L Banko; Lingfei Hou; Francis Poulin; Nahum Sonenberg; Eric Klann
Journal:  J Neurosci       Date:  2006-02-22       Impact factor: 6.167

9.  The Concise Guide to PHARMACOLOGY 2013/14: ion channels.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; William A Catterall; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

10.  The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands.

Authors:  Adam J Pawson; Joanna L Sharman; Helen E Benson; Elena Faccenda; Stephen P H Alexander; O Peter Buneman; Anthony P Davenport; John C McGrath; John A Peters; Christopher Southan; Michael Spedding; Wenyuan Yu; Anthony J Harmar
Journal:  Nucleic Acids Res       Date:  2013-11-14       Impact factor: 16.971

View more
  4 in total

Review 1.  Metabotropic glutamate receptor subtype 5: molecular pharmacology, allosteric modulation and stimulus bias.

Authors:  K Sengmany; K J Gregory
Journal:  Br J Pharmacol       Date:  2015-11-11       Impact factor: 8.739

2.  Sensitization of glutamate receptor-mediated pain behaviour via nerve growth factor-dependent phosphorylation of transient receptor potential V1 under inflammatory conditions.

Authors:  Takayoshi Masuoka; Yuka Yamashita; Junko Yoshida; Katsuya Nakano; Masashi Tawa; Matomo Nishio; Takaharu Ishibashi
Journal:  Br J Pharmacol       Date:  2020-07-20       Impact factor: 8.739

3.  Long-Term Activation of Group I Metabotropic Glutamate Receptors Increases Functional TRPV1-Expressing Neurons in Mouse Dorsal Root Ganglia.

Authors:  Takayoshi Masuoka; Makiko Kudo; Junko Yoshida; Takaharu Ishibashi; Ikunobu Muramatsu; Nobuo Kato; Noriko Imaizumi; Matomo Nishio
Journal:  Front Cell Neurosci       Date:  2016-03-31       Impact factor: 5.505

4.  TRPA1 Channels Modify TRPV1-Mediated Current Responses in Dorsal Root Ganglion Neurons.

Authors:  Takayoshi Masuoka; Makiko Kudo; Yuka Yamashita; Junko Yoshida; Noriko Imaizumi; Ikunobu Muramatsu; Matomo Nishio; Takaharu Ishibashi
Journal:  Front Physiol       Date:  2017-05-03       Impact factor: 4.566

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.